Financhill
Back

Glaukos Quote, Financials, Valuation and Earnings

Glaukos Price Quote

$150.91
+0.03 (+4.99%)
(Updated: December 21, 2024 at 5:28 AM ET)

Glaukos Key Stats

Buy
60
Glaukos (GKOS) is a Buy

Day range:
$141.53 - $151.12
52-week range:
$74.75 - $151.12
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
21.38
P/B ratio:
12.44%

Volume:
1M
Avg. volume:
549.4K
1-year change:
89.55%
Market cap:
$8.3B
Revenue:
$314.7M
EPS:
$-2.96

How Much Does Glaukos Make?

Data Unavailable

Is Glaukos Growing As A Company?

Data Unavailable

Glaukos Stock Price Performance

  • Did Glaukos Stock Go Up Last Month?
    Glaukos share price went up by 6.67% last month
  • Did GKOS's Share Price Rise Over The Last Year?
    GKOS share price rose by 89.55% over the past 1 year

What Is Glaukos 52-Week High & Low?

  • What Is Glaukos’s 52-Week High Share Price?
    Glaukos has traded as high as $151.12 over the past 52 weeks
  • What Is Glaukos’s 52-Week Low Share Price?
    Glaukos has traded as low as $74.75 over the past 52 weeks

Glaukos Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Glaukos?

Data Unavailable

Is Glaukos Cash Flow Positive?

Data Unavailable

Glaukos Return On Invested Capital

Data Unavailable

Glaukos Earnings Date & Stock Price

  • What Is Glaukos's Stock Price Today?
    A single share of GKOS can be purchased today for 150.88
  • What Is Glaukos’s Stock Symbol?
    Glaukos trades on the nyse under the ticker symbol: GKOS
  • When Is Glaukos’s Next Earnings Date?
    The next quarterly earnings date for Glaukos is scheduled on February 21, 2025
  • When Is GKOS's next ex-dividend date?
    Glaukos's next ex-dividend date is December 22, 2024
  • How To Buy Glaukos Stock?
    You can buy Glaukos shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Glaukos Competitors

  • Who Are Glaukos's Competitors?
    Below is a list of companies who compete with Glaukos or are related in some way:
    • Boston Scientific Corp (BSX)
    • Globus Medical Inc (GMED)
    • Intuitive Surgical Inc (ISRG)
    • Masimo Corp (MASI)
    • Stryker Corp (SYK)

Glaukos Dividend Yield

Data Unavailable

Glaukos Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 41.43%
Revenue: 23.86% 5.69%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable